Ever since the invention of SELEX (systematic evolution of ligands by exponential
enrichment), there has been rapid development for aptamers over the last two decades …

Aptamers are chemical antibodies that bind to their targets with high affinity and specificity.
These short stretches of nucleic acids are identified using a repetitive in vitro selection and …

Aptamers continue to receive interest as potential therapeutic agents for the treatment of
diseases, including cancer. In order to determine whether aptamers might eventually prove …

AIM: Single-walled carbon nanotubes (SWNTs) have been already used as drug carriers. In
this study, we introduced sgc8c aptamer (this aptamer targets leukemia biomarker protein …

Aptamers are short nucleic acids that bind to defined targets with high affinity and specificity.
The first aptamers have been selected about two decades ago by an in vitro process named …

Aptamers are nucleic acid-based ligands identified through a process of molecular evolution
named SELEX (Systematic Evolution of Ligands by Exponential enrichment). During the last …

Because of their easily modified chemical structures and wide range of targets, aptamers are
ideal candidates for various applications, such as biomarker discovery, target diagnosis …

Aptamers are a new class of single-stranded DNA/RNA molecules selected from synthetic
nucleic acid libraries for molecular recognition. Our group reports a novel aptamer column …

Circulating endothelial progenitor cells (EPCs) in the peripheral blood of adults represent an
auspicious cell source for tissue engineering of an autologous endothelium on blood …

A growing number of RNA aptamers have been selected experimentally using the SELEX
combinatorial approach, and these aptamers have several advantages over monoclonal …